During the past decade, Hospital Slany, Internal Department conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Slany, Internal Department" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Slany, Internal Department" are "Atrial Fibrillation" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Kidney Disease, Chronic" (1 trials) and "Percutaneous Coronary Intervention" (1 trials). Many other conditions were trialed in "Hospital Slany, Internal Department" in a lesser frequency.

Most popular intervention types in "Hospital Slany, Internal Department" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (1 trials), "BI 690517" (1 trials), "Clopidogrel or Ticagrelor" (1 trials), "Dabigatran Etexilate 110mg" (1 trials) and "Dabigatran Etexilate 150mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Slany, Internal Department" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Slany, Internal Department". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hospital Slany, Internal Department, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Slany, Internal Department, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".